481 related articles for article (PubMed ID: 26981236)
1. miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study.
Sørensen SS; Nygaard AB; Christensen T
Transl Neurodegener; 2016; 5():6. PubMed ID: 26981236
[TBL] [Abstract][Full Text] [Related]
2. miRNA expression profiles in cerebrospinal fluid and blood of patients with acute ischemic stroke.
Sørensen SS; Nygaard AB; Nielsen MY; Jensen K; Christensen T
Transl Stroke Res; 2014 Dec; 5(6):711-8. PubMed ID: 25127724
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data.
Satoh J; Kino Y; Niida S
Biomark Insights; 2015; 10():21-31. PubMed ID: 25922570
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease.
Dakterzada F; Targa A; Benítez ID; Romero-ElKhayat L; de Gonzalo-Calvo D; Torres G; Moncusí-Moix A; Huerto R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G
Alzheimers Res Ther; 2020 Dec; 12(1):163. PubMed ID: 33278902
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
[TBL] [Abstract][Full Text] [Related]
6. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
[TBL] [Abstract][Full Text] [Related]
7. Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease?
Yılmaz ŞG; Erdal ME; Özge AA; Sungur MA
OMICS; 2016 Aug; 20(8):456-61. PubMed ID: 27501295
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of microRNA profiling in one Chinese Family with PSEN1 G378E mutation.
Lv Z; Hu L; Yang Y; Zhang K; Sun Z; Zhang J; Zhang L; Hao Y
Metab Brain Dis; 2018 Oct; 33(5):1711-1720. PubMed ID: 29961914
[TBL] [Abstract][Full Text] [Related]
9. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
[TBL] [Abstract][Full Text] [Related]
11. Altered Cerebrospinal Fluid Exosomal microRNA Levels in Young-Onset Alzheimer's Disease and Frontotemporal Dementia.
Tan YJ; Wong BYX; Vaidyanathan R; Sreejith S; Chia SY; Kandiah N; Ng ASL; Zeng L
J Alzheimers Dis Rep; 2021; 5(1):805-813. PubMed ID: 34870106
[TBL] [Abstract][Full Text] [Related]
12. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
Gui Y; Liu H; Zhang L; Lv W; Hu X
Oncotarget; 2015 Nov; 6(35):37043-53. PubMed ID: 26497684
[TBL] [Abstract][Full Text] [Related]
13. Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer's disease.
Derkow K; Rössling R; Schipke C; Krüger C; Bauer J; Fähling M; Stroux A; Schott E; Ruprecht K; Peters O; Lehnardt S
PLoS One; 2018; 13(7):e0200602. PubMed ID: 30011310
[TBL] [Abstract][Full Text] [Related]
14. Positive regulation of innate immune response by miRNA-let-7a-5p.
Ueta M; Nishigaki H; Komai S; Mizushima K; Tamagawa-Mineoka R; Naito Y; Katoh N; Sotozono C; Kinoshita S
Front Genet; 2022; 13():1025539. PubMed ID: 36685889
[No Abstract] [Full Text] [Related]
15. miRNA expression profiling of cerebrospinal fluid in patients with aneurysmal subarachnoid hemorrhage.
Stylli SS; Adamides AA; Koldej RM; Luwor RB; Ritchie DS; Ziogas J; Kaye AH
J Neurosurg; 2017 Apr; 126(4):1131-1139. PubMed ID: 27128592
[TBL] [Abstract][Full Text] [Related]
16. Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease.
van Harten AC; Mulders J; Scheltens P; van der Flier WM; Oudejans CB
J Alzheimers Dis; 2015; 47(1):243-52. PubMed ID: 26402772
[TBL] [Abstract][Full Text] [Related]
17. Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression.
Liu H; Tian T; Qin S; Li W; Zhang X; Wang X; Gao Y; Huang G
J Nutr Biochem; 2015 Dec; 26(12):1502-8. PubMed ID: 26345540
[TBL] [Abstract][Full Text] [Related]
18. Identification of differential microRNAs in cerebrospinal fluid and serum of patients with major depressive disorder.
Wan Y; Liu Y; Wang X; Wu J; Liu K; Zhou J; Liu L; Zhang C
PLoS One; 2015; 10(3):e0121975. PubMed ID: 25763923
[TBL] [Abstract][Full Text] [Related]
19. Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia.
Piscopo P; Grasso M; Puopolo M; D'Acunto E; Talarico G; Crestini A; Gasparini M; Campopiano R; Gambardella S; Castellano AE; Bruno G; Denti MA; Confaloni A
J Alzheimers Dis; 2018; 65(2):455-464. PubMed ID: 30056425
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
Tan L; Yu JT; Tan MS; Liu QY; Wang HF; Zhang W; Jiang T; Tan L
J Alzheimers Dis; 2014; 40(4):1017-27. PubMed ID: 24577456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
